<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>9(1)</volume><submitter>Nielsen MJ</submitter><pubmed_abstract>Following liver transplantation (LT), 10-30% of patients develop recurrent cirrhosis (RC). There is an urgent need for predictive non-invasive markers for improved monitoring of these patients. Here we studied extracellular matrix biomarkers as predictors of RC after LT. Forty-seven LT patients were divided into groups of fast, intermediate or non-progressors towards RC (&lt;1 year, 3-5 years or no advanced fibrosis >5 years after LT), assessed by follow-up liver biopsies. Markers of interstitial matrix type III and V collagen formation (PRO-C3 and PRO-C5), basement membrane type IV collagen formation (PRO-C4) and degradation (C4M) were assessed in serum samples collected 3, 6 and 12 months post-LT using specific ELISAs. PRO-C3, PRO-C4, and C4M were elevated in fast progressors compared to no</pubmed_abstract><journal>Scientific reports</journal><pagination>14857</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6796007</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Serum markers of type III and IV procollagen processing predict recurrence of fibrosis in liver transplanted patients.</pubmed_title><pmcid>PMC6796007</pmcid><pubmed_authors>Leeming DJ</pubmed_authors><pubmed_authors>Krag A</pubmed_authors><pubmed_authors>Gudmann NS</pubmed_authors><pubmed_authors>Zimmermann T</pubmed_authors><pubmed_authors>Villesen IF</pubmed_authors><pubmed_authors>Nielsen MJ</pubmed_authors><pubmed_authors>Karsdal MA</pubmed_authors><pubmed_authors>Schuppan D</pubmed_authors></additional><is_claimable>false</is_claimable><name>Serum markers of type III and IV procollagen processing predict recurrence of fibrosis in liver transplanted patients.</name><description>Following liver transplantation (LT), 10-30% of patients develop recurrent cirrhosis (RC). There is an urgent need for predictive non-invasive markers for improved monitoring of these patients. Here we studied extracellular matrix biomarkers as predictors of RC after LT. Forty-seven LT patients were divided into groups of fast, intermediate or non-progressors towards RC (&lt;1 year, 3-5 years or no advanced fibrosis >5 years after LT), assessed by follow-up liver biopsies. Markers of interstitial matrix type III and V collagen formation (PRO-C3 and PRO-C5), basement membrane type IV collagen formation (PRO-C4) and degradation (C4M) were assessed in serum samples collected 3, 6 and 12 months post-LT using specific ELISAs. PRO-C3, PRO-C4, and C4M were elevated in fast progressors compared to no</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Oct</publication><modification>2026-05-07T05:54:19.918Z</modification><creation>2026-04-07T22:39:57.912Z</creation></dates><accession>S-EPMC6796007</accession><cross_references><pubmed>31619707</pubmed><doi>10.1038/s41598-019-51394-4</doi></cross_references></HashMap>